356 related articles for article (PubMed ID: 21162527)
1. In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice.
Yang K; Wan J; Zhang S; Zhang Y; Lee ST; Liu Z
ACS Nano; 2011 Jan; 5(1):516-22. PubMed ID: 21162527
[TBL] [Abstract][Full Text] [Related]
2. In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration.
Yang K; Gong H; Shi X; Wan J; Zhang Y; Liu Z
Biomaterials; 2013 Apr; 34(11):2787-95. PubMed ID: 23340196
[TBL] [Abstract][Full Text] [Related]
3. Accumulation and toxicity of intravenously-injected functionalized graphene oxide in mice.
Wen KP; Chen YC; Chuang CH; Chang HY; Lee CY; Tai NH
J Appl Toxicol; 2015 Oct; 35(10):1211-8. PubMed ID: 26099253
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution, pharmacokinetics and toxicology of Ag2S near-infrared quantum dots in mice.
Zhang Y; Zhang Y; Hong G; He W; Zhou K; Yang K; Li F; Chen G; Liu Z; Dai H; Wang Q
Biomaterials; 2013 May; 34(14):3639-46. PubMed ID: 23415643
[TBL] [Abstract][Full Text] [Related]
5. Surface coating-dependent cytotoxicity and degradation of graphene derivatives: towards the design of non-toxic, degradable nano-graphene.
Li Y; Feng L; Shi X; Wang X; Yang Y; Yang K; Liu T; Yang G; Liu Z
Small; 2014 Apr; 10(8):1544-54. PubMed ID: 24376215
[TBL] [Abstract][Full Text] [Related]
6. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power.
Yang K; Wan J; Zhang S; Tian B; Zhang Y; Liu Z
Biomaterials; 2012 Mar; 33(7):2206-14. PubMed ID: 22169821
[TBL] [Abstract][Full Text] [Related]
7. Nano-graphene in biomedicine: theranostic applications.
Yang K; Feng L; Shi X; Liu Z
Chem Soc Rev; 2013 Jan; 42(2):530-47. PubMed ID: 23059655
[TBL] [Abstract][Full Text] [Related]
8. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy.
Yang K; Zhang S; Zhang G; Sun X; Lee ST; Liu Z
Nano Lett; 2010 Sep; 10(9):3318-23. PubMed ID: 20684528
[TBL] [Abstract][Full Text] [Related]
9. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide.
Zhang W; Guo Z; Huang D; Liu Z; Guo X; Zhong H
Biomaterials; 2011 Nov; 32(33):8555-61. PubMed ID: 21839507
[TBL] [Abstract][Full Text] [Related]
11. Differential nano-bio interactions and toxicity effects of pristine versus functionalized graphene.
Sasidharan A; Panchakarla LS; Chandran P; Menon D; Nair S; Rao CN; Koyakutty M
Nanoscale; 2011 Jun; 3(6):2461-4. PubMed ID: 21562671
[TBL] [Abstract][Full Text] [Related]
12. Magnetic PEGylated Pt3Co nanoparticles as a novel MR contrast agent: in vivo MR imaging and long-term toxicity study.
Yin S; Li Z; Cheng L; Wang C; Liu Y; Chen Q; Gong H; Guo L; Li Y; Liu Z
Nanoscale; 2013 Dec; 5(24):12464-73. PubMed ID: 24165858
[TBL] [Abstract][Full Text] [Related]
13. Effect of poly(ethylene imine) molecular weight and pegylation on organ distribution and pharmacokinetics of polyplexes with oligodeoxynucleotides in mice.
Fischer D; Osburg B; Petersen H; Kissel T; Bickel U
Drug Metab Dispos; 2004 Sep; 32(9):983-92. PubMed ID: 15319340
[TBL] [Abstract][Full Text] [Related]
14. In vivo pharmacokinetics, long-term biodistribution and toxicology study of functionalized upconversion nanoparticles in mice.
Cheng L; Yang K; Shao M; Lu X; Liu Z
Nanomedicine (Lond); 2011 Oct; 6(8):1327-40. PubMed ID: 21834646
[TBL] [Abstract][Full Text] [Related]
15. Cell uptake survey of pegylated nanographene oxide.
Vila M; Portolés MT; Marques PA; Feito MJ; Matesanz MC; Ramírez-Santillán C; Gonçalves G; Cruz SM; Nieto A; Vallet-Regi M
Nanotechnology; 2012 Nov; 23(46):465103. PubMed ID: 23093209
[TBL] [Abstract][Full Text] [Related]
16. Intracellular imaging with a graphene-based fluorescent probe.
Peng C; Hu W; Zhou Y; Fan C; Huang Q
Small; 2010 Aug; 6(15):1686-92. PubMed ID: 20602429
[TBL] [Abstract][Full Text] [Related]
17. In vivo biodistribution and toxicology of carboxylated graphene quantum dots.
Nurunnabi M; Khatun Z; Huh KM; Park SY; Lee DY; Cho KJ; Lee YK
ACS Nano; 2013 Aug; 7(8):6858-67. PubMed ID: 23829293
[TBL] [Abstract][Full Text] [Related]
18. Surface-engineered graphene navigate divergent biological outcomes toward macrophages.
Luo N; Ni D; Yue H; Wei W; Ma G
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5239-47. PubMed ID: 25692327
[TBL] [Abstract][Full Text] [Related]
19. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
[TBL] [Abstract][Full Text] [Related]
20. Investigating oxidation state-induced toxicity of PEGylated graphene oxide in ocular tissue using gene expression profiles.
Wu W; Yan L; Chen S; Li Q; Gu Z; Xu H; Yin ZQ
Nanotoxicology; 2018 Oct; 12(8):819-835. PubMed ID: 29888639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
